April 15, 2015 | The Israeli stem cell solutions company Accellta announced that it signed an exclusive agreement with the international company Stem Cell Technologies. As part of the agreement, Stem Cell Technologies will market Accellta’s culturing platform that grows stem cells. Accellta was founded at the AMIT Institute of the Technion Israel Institute of Technology.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Israeli Startup Rings Closing Bell At Nasdaq in NYC
March 28, 2024
Israeli, US Companies Unite To Make More Milk From Mushrooms
March 27, 2024
Facebook comments